[Dr.Vad]

For patients with lower risk MDS who have other severe cytopenias beyond anemia, the most appropriate treatment approach is less clear29. Neutropenia in patients with MDS often does respond to use of myeloid growth factors, but these have never been shown to improve survival in MDS and have minimal effect on reducing infection risk11
---
Myelodysplastic syndromes current treatment algorithm 2018
[Ссылки доступны только зарегистрированным пользователям ]